WTC
HUMA icon

WhitTier Trust Company’s Humacyte HUMA Stock Holding History

WhitTier Trust Company’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$21K – 1291
2025
Q3 		$21K Hold
10,000
– – ﹤0.01% 885
2025
Q2 		$20.8K Hold
10,000
– – ﹤0.01% 983
2025
Q1 		$17K Hold
10,000
– – ﹤0.01% 1005
2024
Q4 		$50.5K Hold
10,000
– – ﹤0.01% 755
2024
Q3 		$54.4K Hold
10,000
– – ﹤0.01% 730
2024
Q2 		$47.9K Hold
10,000
– – ﹤0.01% 711
2024
Q1 		$31K Hold
10,000
– – ﹤0.01% 770
2023
Q4 		$28.3K Buy
+10,000
New +$25.7K ﹤0.01% 767

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WhitTier Trust Company's HUMA Position: Q4 2025 in Review

WhitTier Trust Company sold out of Humacyte (HUMA) in Q4 2025, closing a stake of 10,000 shares — an estimated $21K sold.

WhitTier Trust Company first reported a position in HUMA in Q4 2023 and held it in 8 quarters. The position peaked at $54.4K in Q3 2024. 147 funds tracked by Wall St. Rank hold HUMA as of Q4 2025.

  • WhitTier Trust Company reported no remaining Humacyte position as of Q4 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 10,000 Humacyte shares in Q4 2025, an estimated $21K.
  • WhitTier Trust Company first reported a position in Humacyte in Q4 2023 and held it in 8 quarters.
  • WhitTier Trust Company's Humacyte position peaked at $54.4K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Humacyte as of Q4 2025.

Based on WhitTier Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.